# Microbiota and Probiotic Therapy in Ulcerative Colitis Patients

> **NCT07180186** · — · COMPLETED · sponsor: **Tanta University** · enrollment: 70 (actual)

## Conditions studied

- Microbiota
- Probiotic Therapy
- Ulcerative Colitis

## Interventions

- **DRUG:** Mesalamine
- **DRUG:** Probiotics (Bacillus Clausii)
- **DRUG:** Mesalamine and probiotics (Bacillus Clausii)

## Key facts

- **NCT ID:** NCT07180186
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07180186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07180186, "Microbiota and Probiotic Therapy in Ulcerative Colitis Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07180186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*